A5003811969- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- EEG and Brain-Computer Interfaces
- Health Systems, Economic Evaluations, Quality of Life
- Polyomavirus and related diseases
- Myasthenia Gravis and Thymoma
- Full-Duplex Wireless Communications
- Botulinum Toxin and Related Neurological Disorders
- Immunodeficiency and Autoimmune Disorders
- Schizophrenia research and treatment
- Autoimmune Neurological Disorders and Treatments
- Dermatological and Skeletal Disorders
- Palliative Care and End-of-Life Issues
- Alkaline Phosphatase Research Studies
- Transcranial Magnetic Stimulation Studies
- Skin and Cellular Biology Research
- Multiple Sclerosis Research Studies
- Neurological and metabolic disorders
Medical College of Wisconsin
2024
University of Michigan
2019-2020
VA Ann Arbor Healthcare System
2020
University of Pittsburgh Medical Center
2019
UPMC Health System
2018
Progressive multifocal leukoencephalopathy (PML) is a life-threatening central nervous system (CNS) disorder, most commonly described in patients infected with the human immunodeficiency virus (HIV). Limited data exist on its natural history and treatment solid organ transplant (SOT) recipients. A complication of PML immune reconstitution inflammatory syndrome (IRIS), which develops after T cell can have severe consequences when it occurs CNS. While well HIV-infected individuals, clinical...
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning / CMESubscribeJobsInstitutions LibrariansReprints Permissions Terms Use Privacy...
Abstract Objectives Selection of autoimmune/paraneoplastic antibody panels remains challenging because health-care professionals often lack familiarity with panel contents, recommended specimen types, and combinations for a given patient. Inappropriate use adds cost, prompts unnecessary additional workup, delays the identification true cause patient symptoms. In this study, we assessed whether order-entry clinical decision support can improve utilization. Methods An tool was embedded in...
In patients who are treated with deep brain stimulation for Parkinson disease and have previously been dopamine agonists, new psychiatric symptoms may be a manifestation of the agonist withdrawal syndrome even if symptom onset does not coincide drug taper. These reversible reintroduction at low doses.
April 24, 2018April 10, 2018Free AccessTesting and Turnaround Time for Stat EEGs: How do we get faster? (P3.262)Brian Hanrahan, Eric Jackowiak, James Lee, Stephanie Paolini, Anto Bagic, Alexandra PopescuAuthors Info & AffiliationsApril 2018 issue90 (15_supplement) Letters to the Editor
Advance Care Planning (ACP) is one of 10 key elements in the American Academy Neurology Parkinson disease (PD) clinical practice quality measures. We know little about how aging influences ACP views people with PD.We conducted a cross-sectional survey 39 participants (mean age 70.3 years; range: 52-81) PD to explore correlations between older and life-sustaining treatment preferences while controlling for confounders including years education, Montreal Cognitive Assessment score Movement...